Desloratadine 5 mg - rezultati pretrage

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

desloratadine tablet, film coated

sun pharmaceutical industries, inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug- associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats

Sjedinjene Američke Države - engleski - NLM (National Library of Medicine)

desloratadine tablet, film coated

a-s medication solutions - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)]. risk summary the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratogenic at the summed area under the concentration-time curve (auc)-based exposures of desloratadine and its metabolite approximately 320 times that at the recommended human daily oral dose (r

Velika Britanija - engleski - MHRA (Medicines & Healthcare Products Regulatory Agency)

desloratadine 2.5mg5ml oral solution sugar free

actavis uk ltd - desloratadine - oral solution - 500microgram/1ml

Irska - engleski - HPRA (Health Products Regulatory Authority)

desloratadine 5mg film-coated tablets

accord healthcare ireland ltd. - desloratidine - film-coated tablet - 5 milligram(s) - other antihistamines for systemic use; desloratadine

Izrael - engleski - Ministry of Health

aerius tablets

organon pharma israel ltd., israel - desloratadine - tablets - desloratadine 5 mg - desloratadine - desloratadine - aerius tablet is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with:- allergic rhinitis - urticaria